$33.83
+1.36
(+4.19%)▲
3.88%
Downside
Day's Volatility :6.61%
Upside
2.84%
69.52%
Downside
52 Weeks Volatility :72.23%
Upside
8.89%
Period | Pennant Group Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 46.73% | 7.5% | 0.0% |
6 Months | 75.69% | 6.9% | 0.0% |
1 Year | 226.92% | 20.9% | 0.0% |
3 Years | 31.3% | 21.0% | -21.1% |
Market Capitalization | 1.1B |
Book Value | $5.1 |
Earnings Per Share (EPS) | 0.66 |
PE Ratio | 54.09 |
PEG Ratio | 2.45 |
Wall Street Target Price | 33.5 |
Profit Margin | 3.16% |
Operating Margin TTM | 5.67% |
Return On Assets TTM | 3.58% |
Return On Equity TTM | 13.14% |
Revenue TTM | 611.8M |
Revenue Per Share TTM | 20.38 |
Quarterly Revenue Growth YOY | 27.6% |
Gross Profit TTM | 103.1M |
EBITDA | 37.5M |
Diluted Eps TTM | 0.66 |
Quarterly Earnings Growth YOY | 1.0 |
EPS Estimate Current Year | 0.92 |
EPS Estimate Next Year | 1.07 |
EPS Estimate Current Quarter | 0.21 |
EPS Estimate Next Quarter | 0.23 |
What analysts predicted
Downside of 0.98%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 286.1M | ↑ 13.97% |
Net Income | 15.7M | ↑ 58.95% |
Net Profit Margin | 5.48% | ↑ 1.55% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 338.5M | ↑ 18.34% |
Net Income | 2.5M | ↓ 83.77% |
Net Profit Margin | 0.75% | ↓ 4.73% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 391.0M | ↑ 15.49% |
Net Income | 15.7M | ↑ 518.38% |
Net Profit Margin | 4.03% | ↑ 3.28% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 439.7M | ↑ 12.47% |
Net Income | 2.1M | ↓ 86.36% |
Net Profit Margin | 0.49% | ↓ 3.54% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 473.2M | ↑ 7.63% |
Net Income | 6.6M | ↑ 209.26% |
Net Profit Margin | 1.4% | ↑ 0.91% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 544.9M | ↑ 15.14% |
Net Income | 13.4M | ↑ 101.4% |
Net Profit Margin | 2.46% | ↑ 1.06% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 126.5M | ↑ 1.44% |
Net Income | 1.9M | ↓ 46.75% |
Net Profit Margin | 1.46% | ↓ 1.33% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 132.3M | ↑ 4.6% |
Net Income | 2.8M | ↑ 51.19% |
Net Profit Margin | 2.11% | ↑ 0.65% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 140.2M | ↑ 5.98% |
Net Income | 4.4M | ↑ 56.7% |
Net Profit Margin | 3.13% | ↑ 1.02% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 146.0M | ↑ 4.11% |
Net Income | 4.3M | ↓ 0.78% |
Net Profit Margin | 2.98% | ↓ 0.15% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 156.9M | ↑ 7.51% |
Net Income | 4.9M | ↑ 12.81% |
Net Profit Margin | 3.13% | ↑ 0.15% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 168.7M | ↑ 7.54% |
Net Income | 5.7M | ↑ 15.98% |
Net Profit Margin | 3.37% | ↑ 0.24% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 98.2M | ↑ 11.17% |
Total Liabilities | 32.9M | ↑ 15.82% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 447.8M | ↑ 356.18% |
Total Liabilities | 376.6M | ↑ 1046.09% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 507.0M | ↑ 13.23% |
Total Liabilities | 405.8M | ↑ 7.74% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 530.3M | ↑ 4.6% |
Total Liabilities | 416.1M | ↑ 2.53% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 512.1M | ↓ 3.43% |
Total Liabilities | 386.5M | ↓ 7.11% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 539.7M | ↑ 5.38% |
Total Liabilities | 394.2M | ↑ 2.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 508.2M | ↓ 0.77% |
Total Liabilities | 378.9M | ↓ 1.95% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 515.4M | ↑ 1.43% |
Total Liabilities | 381.7M | ↑ 0.73% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 520.3M | ↑ 0.95% |
Total Liabilities | 380.8M | ↓ 0.24% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 539.7M | ↑ 3.72% |
Total Liabilities | 394.2M | ↑ 3.51% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 578.2M | ↑ 7.14% |
Total Liabilities | 414.0M | ↑ 5.03% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 602.5M | ↑ 4.19% |
Total Liabilities | 429.5M | ↑ 3.73% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 23.3M | ↑ 34.93% |
Investing Cash Flow | -9.5M | ↓ 41.07% |
Financing Cash Flow | -13.8M | ↑ 1088.03% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 9.6M | ↓ 58.95% |
Investing Cash Flow | -26.5M | ↑ 179.26% |
Financing Cash Flow | 17.3M | ↓ 225.22% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 50.2M | ↑ 425.48% |
Investing Cash Flow | -41.6M | ↑ 57.25% |
Financing Cash Flow | -8.9M | ↓ 151.8% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -18.2M | ↓ 136.3% |
Investing Cash Flow | -20.1M | ↓ 51.65% |
Financing Cash Flow | 43.5M | ↓ 586.08% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 9.0M | ↓ 149.63% |
Investing Cash Flow | -24.2M | ↑ 20.47% |
Financing Cash Flow | 12.1M | ↓ 72.21% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 9.0M | ↓ 328.91% |
Investing Cash Flow | -2.3M | ↓ 42.75% |
Financing Cash Flow | -5.8M | ↓ 181.45% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 6.5M | ↓ 27.33% |
Investing Cash Flow | -8.9M | ↑ 282.63% |
Financing Cash Flow | 2.2M | ↓ 138.8% |
Sell
Neutral
Buy
Pennant Group Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Pennant Group Inc | 9.88% | 75.69% | 226.92% | 31.3% | 132.57% |
Fresenius Medical Care Ag | 10.94% | 13.12% | 0.33% | -39.59% | -33.54% |
Hca Holdings, Inc. | 2.68% | 22.34% | 66.58% | 66.31% | 250.52% |
Tenet Healthcare Corp. | 2.81% | 61.22% | 162.93% | 147.69% | 693.7% |
Universal Health Services Inc. | -3.15% | 31.81% | 83.47% | 68.5% | 57.54% |
Davita Healthcare Partners Inc. | 7.86% | 21.17% | 74.91% | 41.69% | 193.41% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Pennant Group Inc | 54.09 | 54.09 | 2.45 | 0.92 | 0.13 | 0.04 | NA | 5.1 |
Fresenius Medical Care Ag | 21.1 | 21.1 | 0.43 | 2.35 | 0.05 | 0.03 | 0.03 | 47.48 |
Hca Holdings, Inc. | 19.09 | 19.09 | 1.23 | 22.57 | 0.74 | 0.11 | 0.01 | -6.17 |
Tenet Healthcare Corp. | 6.05 | 6.05 | 0.83 | 10.57 | 0.55 | 0.07 | NA | 36.27 |
Universal Health Services Inc. | 16.83 | 16.83 | 1.87 | 15.95 | 0.15 | 0.06 | 0.0 | 97.21 |
Davita Healthcare Partners Inc. | 17.46 | 17.46 | 1.52 | 9.8 | 0.45 | 0.07 | NA | 7.44 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Pennant Group Inc | Buy | $1.1B | 132.57% | 54.09 | 3.16% |
Fresenius Medical Care Ag | Hold | $12.6B | -33.54% | 21.1 | 2.73% |
Hca Holdings, Inc. | Buy | $104.9B | 250.52% | 19.09 | 8.4% |
Tenet Healthcare Corp. | Buy | $15.9B | 693.7% | 6.05 | 13.18% |
Universal Health Services Inc. | Hold | $15.3B | 57.54% | 16.83 | 6.22% |
Davita Healthcare Partners Inc. | Hold | $13.8B | 193.41% | 17.46 | 6.86% |
Insights on Pennant Group Inc
Revenue is up for the last 11 quarters, 111.76M → 168.74M (in $), with an average increase of 4.0% per quarter
Netprofit is up for the last 3 quarters, 4.34M → 5.69M (in $), with an average increase of 12.6% per quarter
In the last 3 years, Tenet Healthcare Corp. has given 141.5% return, outperforming this stock by 114.2%
BlackRock Inc
Vanguard Group Inc
T. Rowe Price Investment Management,Inc.
FMR Inc
Riverbridge Partners LLC
Wasatch Advisors LP
cornerstone service center, inc. supports the companies of cornerstone healthcare, inc. (which is itself a subsidiary of the ensign group, inc. - nasdaq ensg). cornerstone healthcare, inc. focuses on acquiring, operating, and expanding home health, hospice and private duty companies in the united states with current operations in california, oregon, washington, idaho, utah, arizona, colorado, texas & iowa.
Organization | Pennant Group Inc |
Employees | 5791 |
CEO | Mr. Brent J. Guerisoli |
Industry | Health Services |
Spdr S&p Global Dividend Etf
$33.83
+4.19%
Flotek Industries Inc
$33.83
+4.19%
Bank Of N.t. Butterfield & Son Limited
$33.83
+4.19%
Trio Petroleum Corp
$33.83
+4.19%
Ft Cboe Vest Us Eqy D Bu-may
$33.83
+4.19%
Cherry Hill Mortgage Investment Corp
$33.83
+4.19%
Invesco Bulletshares 2025 Hi
$33.83
+4.19%
Invesco Large Cap Value Etf
$33.83
+4.19%
Ft Cboe Vest Us Equity Moderate Buffer Etf - Apr
$33.83
+4.19%